How to Tell If a Peptide Clinic Is Actually Following the Rules

By Dr. Farhan Abdullah, DO | Medical Director, Magnolia Functional Wellness | Southlake, TX

A patient showed me her phone in clinic a few weeks back. She'd found an ad for weight loss injections online: no doctor visit required, no bloodwork, just fill out a questionnaire and a vial shows up in the mail a few days later. The price was less than half of what we charge at Magnolia Functional Wellness. She wasn't asking me to match it. She was asking, genuinely, whether it was safe. That's a fair question, and I get some version of it more often now that peptide medications like semaglutide and tirzepatide have become household names, popping up in ads on the same feed as her kids' soccer schedule from a Southlake rec league. So let's actually answer it, because "trust me" isn't good enough, and it shouldn't be.

I've spent years training in functional and hormone medicine, and I still send patients home with homework before we start a peptide medication, not after. If a clinic skips that step entirely, that tells you something on its own. Here's what I look for, and what I'd want any patient looking for, whether you're evaluating us at Magnolia Functional Wellness or evaluating somebody else entirely. None of it requires a medical degree. It just requires knowing which questions actually separate a licensed medical practice from a fulfillment operation wearing a white coat.

Start With Where the Medication Actually Comes From

Compounded medications aren't automatically a problem. Compounding pharmacies serve a real and legitimate need, especially when a commercial supply runs short or a patient needs a dose strength that isn't sold on the shelf. But compounding happens under a different regulatory framework than the one that governs a manufactured, FDA-approved drug, and that difference matters more than most patients realize.

Semaglutide, as a drug substance, is what two FDA-approved products, Ozempic and Wegovy, are built on. Tirzepatide is what Mounjaro and Zepbound are built on. A compounded version of either one is prepared by a licensed pharmacy under a doctor's prescription, and it is a distinct product from those brand-name medications, made under different oversight, without the FDA approval that attaches specifically to the brand. That's not a knock against compounding as a practice. It's just the truth, and any clinic worth your trust should say it plainly instead of letting the line blur.

Ask which pharmacy the clinic uses. A legitimate practice can tell you, by name, and can usually tell you whether it's what's called a 503A or 503B facility. Those aren't interchangeable labels, and a clinic that can rattle off the difference without hesitating has almost certainly done its homework on the front end. If you get a vague answer, or the staff seems irritated that you asked, notice that. A 2026 pharmacovigilance analysis published in Frontiers in Pharmacology by Zinzi and colleagues examined real-world adverse event reports tied to counterfeit semaglutide products moving outside legitimate supply chains, and the pattern held up: harm clustered around products with murky, unverifiable sourcing. Sourcing isn't a technicality you can wave off. It's the first place quality control either exists or doesn't.

I'd also ask how the medication is stored and shipped. Semaglutide and tirzepatide are temperature-sensitive proteins, and a vial that sat in a hot mailbox on a July afternoon in North Texas has a real chance of losing potency before it ever reaches you. A clinic that hands you the medication directly, or ships it with proper cold packaging and tracking, is telling you something about how seriously it takes the product between the pharmacy and your refrigerator. One that shrugs off the question is telling you something too.

A Real Exam Comes Before Any Prescription, Not After

Here's a red flag I take seriously: a clinic that will prescribe a peptide medication off a five-minute online form, with no video visit, no history, and no labs. At Magnolia, before we start anyone on semaglutide or tirzepatide, we're looking at their metabolic history, their family history (thyroid cancer runs in some families, and that matters here), kidney function, and often a baseline A1c or metabolic panel. That's not us being cautious for the sake of it. It's the standard of care, and it exists because these medications, even the FDA-approved brand-name ones, carry real contraindications for a meaningful subset of patients.

If a clinic never asks about your medical history in a way that would let a doctor actually say no to you, that clinic isn't practicing medicine. It's fulfilling an order. Those are different things, and only one of them is designed to catch a problem before it becomes yours. I've turned away patients who wanted to start that same week, not because I enjoy saying no, but because their labs came back showing something that needed attention first. A clinic that never says no to anybody isn't screening anybody either.

I'd also ask what happens if you have a bad reaction. Is there a physician you can reach, or a number that rings a call center? A 2025 review in The American Journal of Managed Care by Liu and colleagues, written specifically to help health care providers navigate the compounded semaglutide landscape, pointed out something worth repeating to patients directly: the clinics best positioned to catch complications are the ones with an actual prescriber attached to the relationship, not a fulfillment pipeline with a doctor's name stamped on it somewhere upstream.

Dosing Should Move Slowly, and On Paper

Titration is not a suggestion. These medications work by slowing gastric emptying and changing appetite signaling, and if you push the dose up too fast, the most common result is severe nausea, vomiting, and dehydration, not faster results. What I tell my patients is that the dose schedule should be written down, specific to them, and adjustable based on how they're tolerating it, not a flat instruction sheet that treats a 5-foot-2 grandmother and a 6-foot-4 former athlete identically.

This isn't theoretical. A case series published in the Journal of the American Pharmacists Association by Lambson and colleagues documented administration errors with compounded semaglutide reported to a poison control center, several involving patients who measured or dosed incorrectly because the product came without clear, individualized instructions. Separately, a 2026 pharmacovigilance study in Expert Opinion on Drug Safety by McCall and colleagues, analyzing reports submitted to the FDA's adverse event reporting system, found a disproportionate signal for dosing-related problems specifically tied to compounded GLP-1 products compared to their branded counterparts. That doesn't mean compounded medications are inherently dangerous. It means the margin for error narrows fast when nobody is checking your work.

Ask, plainly, who reviews your dose before each refill. If the honest answer is "nobody, it just ships," that's your answer about whether this clinic is actually practicing medicine.

Follow-Up Care Matters as Much as the First Visit

The intake visit gets all the attention, but in my experience it's the follow-up that separates a clinic that's actually managing your care from one that's just refilling a prescription on autopilot. Are you being asked how you're tolerating the medication three or four weeks in? Is anyone checking whether your nausea has settled or gotten worse, whether you're losing weight at a pace that's sustainable, whether your labs need a recheck before the next dose increase? At Magnolia, that ongoing conversation is built into the plan from day one, not something you have to fight for after the fact.

This matters more than it sounds like it should, because peptide medication therapy isn't a one-time transaction. It's a relationship that runs for months, sometimes years, and the patients who do best are the ones whose treatment gets adjusted along the way instead of staying frozen at whatever dose they started on. If a clinic's entire follow-up plan is an automated refill reminder, that's not follow-up. That's a subscription.

Marketing Claims That Should Make You Pause

Some of this you can spot before you ever set foot in the building. Watch for language claiming a compounded product is "pharmaceutical grade," or that it's "the same as" the brand name, or that it's "clinically proven" using data that actually came from trials of the FDA-approved drug rather than the compounded version. None of those claims are ones a compliant clinic can honestly make, because they blur a distinction regulators take seriously for good reason: the compounded product hasn't gone through the same review the branded one has, whatever else may be true about it.

I'd also be wary of guaranteed weight-loss numbers, "as low as" pricing that doesn't hold up once you ask what's actually included, or any clinic that pressures you to commit before a clinician has even reviewed your intake. Watch for testimonials with no last names, before-and-after photos with no context about what else changed in that person's life, or a countdown timer pushing you to sign up before a "limited time" price disappears. Medicine that's being practiced correctly rarely needs a sense of urgency to sell itself.

In my practice, I'd rather lose a patient to a slower decision than rush someone into a treatment plan that isn't right for them. That's a low bar, honestly, but you'd be surprised how many places don't clear it.

What This Looks Like Done Right

At Magnolia Functional Wellness, every peptide medication patient sees a clinician, not just an intake coordinator, before anything gets prescribed. We're transparent about sourcing, we titrate based on how you're actually responding, and we check labs at intervals that make sense for your history, not on a generic template. Southlake has no shortage of options if you're looking for weight loss or hormone support right now, and that's a good thing for patients, as long as you know what to ask.

None of this requires you to become an expert in pharmacy regulation overnight. It just requires asking a few direct questions and paying attention to whether the answers feel like they're coming from a clinician or from a script. If a clinic can't tell you where your medication comes from, who's watching your dose, or what happens if something goes wrong, you already have your answer.

If you're weighing a physician-supervised GLP-1 medication like semaglutide or tirzepatide and want a straight conversation about how it's actually done, that's exactly the kind of visit we do at Magnolia Functional Wellness in Southlake.